FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Cordani David 2. Issuer Name and Ticker or Trading Symbol Cigna Corp [ CI ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
President & CEO
(Last)         (First)         (Middle)
900 COTTAGE GROVE ROAD
3. Date of Earliest Transaction (MM/DD/YYYY)
1/12/2021
(Street)
BLOOMFIELD, CT 06002
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $.01 Par Value  1/12/2021    M(1)    55280.0000  A $58.7300  85774.0000 (2) D   
Common Stock, $.01 Par Value  1/12/2021    S(1)    55280.0000  D $225.0000  30494.0000  D   
Common Stock, $.01 Par Value  1/13/2021    M(1)    13667.0000  A $58.7300  44161.0000  D   
Common Stock, $.01 Par Value                 1640.4521 (3) I  By 401(k) 
Common Stock, $.01 Par Value                 424611.0000 (2) I  By GRAT 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy)  $58.7300  1/12/2021    M (1)       55280.0000   3/5/2014 (4) 3/5/2023  Common Stock, $.01 Par Value  55280.0000  $0.0000  151563.0000  D   
Employee Stock Option (Right to Buy)  $58.7300  1/13/2021    M (1)       13667.0000   3/5/2014 (4) 3/5/2023  Common Stock, $.01 Par Value  13667.0000  $0.0000  137896.0000  D   

Explanation of Responses:
(1)  These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2019.
(2)  Reflects a transfer by the Reporting Person of 237,221 shares of common stock to a grantor retained annuity trust on December 10, 2020.
(3)  Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.
(4)  This option was granted on March 5, 2013. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Cordani David
900 COTTAGE GROVE ROAD
BLOOMFIELD, CT 06002
X
President & CEO

Signatures
By: Jill M. Stadelman, attorney-in-fact 1/14/2021
**Signature of Reporting Person Date